Skip to main content

Table 2 Univariate analysis of prognostic factors related to axillary lymph node invasion

From: Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy

Factor

Variable

No. of women

Positive nodes (%)

Odds ratio

95% CI

P

Histology

Ductal

45

29 (64%)

1.00

  
 

Other

7

6 (86%)

3.31

0.37-29.97

0.287

Tumor mass

Single

36

21 (58%)

1.00

  
 

Other

16

14 (88%)

5.00

0.99-25.34

0.052

Clinical response

No

13

(77%)

1.00

  
 

Yes

39

25 (64%)

0.54

0.13-2.28

0.398

ER

Negative

22

16 (73%)

1.00

  
 

Positive

30

19 (63%)

0.65

0.20-2.14

0.477

PR

Negative

28

21 (75%)

1.00

  
 

Positive

24

14 (58%)

0.47

0.14-1.52

0.205

c-erb-B2

Negative

37

24 (64%)

1.00

  
 

Positive

15

11 (73%)

1.49

0.37-5.62

0.557

53

Negative

34

24 (71%)

1.00

  
 

Positive

18

11 (61%)

0.65

0.20-2.18

0.489

Ki67

<20%

17

6 (35%)

1.00

  
 

≥ 20%

33

27 (82%)

8.25

2.18-31.23

0.002

MDR1 (IHC)

Negative

14

8 (57%)

1.00

  
 

Positive

9

7 (78%)

2.63

0.39-17.46

0.318

LRP

Negative

8

3 (38%)

1.00

  
 

Positive

23

17 (74%)

4.72

0.86-26.04

0.075

MDR1 (RT-PCR)

Negative

24

13 (54%)

1.00

  
 

Positive

22

18 (82%)

3.81

0.99-14.67

0.052

MDR1 (RT-PCR)

Both negative

8

3 (38%)

1.00

  

and LRP combined

      
 

LRP+ MDR1-

7

4 (57%)

2.22

0.28-17.63

0.450

 

Both positive

15

13 (87%)

10.83

1.37-85.43

0.024

  1. CI, confidence interval; ER, estrogen receptor; PR, progesterone receptor; RT-PCR, reverse-transcriptase-mediated polymerase chain reaction.